Therapeutic and biopharmaceutical assessment of indapamide medications
The paper is focussed on the drug release comparison for multisource indapamide medications against the original medication, Arifon retard (1,5 mg; Servier Laboratories, France). The comparative test of dissolution kinetics was performed in three media modelling physiological gastrointestinal condit...
Main Authors: | G. V. Ramenskaya, S. V. Nedogoda, I. E. Shokhin, A. Yu. Savchenko, V. S. Shlykov |
---|---|
Format: | Article |
Language: | Russian |
Published: |
«SILICEA-POLIGRAF» LLC
1970-01-01
|
Series: | Кардиоваскулярная терапия и профилактика |
Subjects: | |
Online Access: | https://cardiovascular.elpub.ru/jour/article/view/2071 |
Similar Items
-
Validation of a dissolution method with RP-HPLC analysis for Perindopril erbumine and Indapamide combination tablet
by: Jain P.S., et al.
Published: (2012-01-01) -
INDAPAMIDE POTENTIAL AT VARIOUS STAGES OF CARDIOVASCULAR CONTINUUM AND IN SPECIFIC CLINICAL GROUPS
by: M. N. Mamedov
Published: (2010-12-01) -
ASSESSMENT OF THERAPEUTICAL EQUIVALENCY OF ORIGINAL AND GENERIC INDAPAMIDE IN HYPERTENSIVE PATIENTS BY RANDOMIZED CROSS-OVER STUDY
by: N. P. Kutishenko, et al.
Published: (2015-12-01) -
Effectiveness and safety of indapamide sustained-release in the treatment of post partial hypertension
by: I R Gaisin, et al.
Published: (2015-06-01) -
Indapamide retard as the medication of choice in elderly patients with arterial hypertension
by: I. I. Chukaeva, et al.
Published: (2013-10-01)